Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)

ClinicalTrials.gov ID: NCT04845620

Public ClinicalTrials.gov record NCT04845620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.05% Administered QD in Subjects With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a Phase 3, 4-week, double-blind study to assess the safety and efficacy of ARQ-151 cream compared to vehicle cream applied once daily (qd) for 4 weeks in children 2 to 5 years of age with atopic dermatitis (AD).

Study identification

NCT ID
NCT04845620
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arcutis Biotherapeutics, Inc.
Industry
Enrollment
652 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2021
Primary completion
May 31, 2023
Completion
May 31, 2023
Last update posted
Dec 22, 2025

2021 – 2023

United States locations

U.S. sites
71
U.S. states
26
U.S. cities
63
Facility City State ZIP Site status
Arcutis Clinical Site 56 Birmingham Alabama 35209
Arcutis Clinical Site 14 Birmingham Alabama 35244
Arcutis Clinical Site 69 Montgomery Alabama 36117
Arcutis Clinical Site 68 Gilbert Arizona 85234
Arcutis Clinical Site 26 Scottsdale Arizona 85255
Arcutis Clinical Site 50 Bryant Arkansas 72022
Arcutis Clinical Site 59 Fort Smith Arkansas 72916
Arcutis Clinical Site 71 Little Rock Arkansas 72212
Arcutis Clinical Site 09 Inglewood California 90301
Arcutis Clinical Site 45 Rancho Santa Margarita California 92688
Arcutis Clinical Site 30 San Diego California 92123
Arcutis Clinical Site 70 Thousand Oaks California 91320
Arcutis Clinical Site 48 Boca Raton Florida 33486
Arcutis Clinical Site 33 Coral Gables Florida 33134
Arcutis Clinical Site 12 Coral Gables Florida 33146
Arcutis Clinical Site 11 Delray Beach Florida 33484
Arcutis Clinical Site 28 Largo Florida 33770
Arcutis Clinical Site 79 Miami Florida 33137
Arcutis Clinical Site 43 Miami Florida 33173
Arcutis Clinical Site 10 Miami Lakes Florida 33014
Arcutis Clinical Site 35 North Miami Beach Florida 33162
Arcutis Clinical Site 75 Wellington Florida 33449
Arcutis Clinical Site 20 Sandy Springs Georgia 30328
Arcutis Clinical Site 82 Boise Idaho 83706
Arcutis Clinical Site 60 Chicago Illinois 60607
Arcutis Clinical Site 07 Rolling Meadows Illinois 33770
Arcutis Clinical Site 42 Clarksville Indiana 47129
Arcutis Clinical Site 21 Plainfield Indiana 46168
Arcutis Clinical Site 57 West Lafayette Indiana 47906
Arcutis Clinical Site 22 Louisville Kentucky 40217
Arcutis Clinical Site 46 Louisville Kentucky 40241
Arcutis Clinical Site 84 Baton Rouge Louisiana 70808
Arcutis Clinical Site 34 Lake Charles Louisiana 70605
Arcutis Clinical Site 51 Metairie Louisiana 70005
Arcutis Clinical Site 40 Metairie Louisiana 70006
Arcutis Clinical Site 77 Columbia Maryland 21045
Arcutis Clinical Site 13 Rockville Maryland 20850
Arcutis Clinical Site 15 Rockville Maryland 20850
Arcutis Clinical Site 53 Auburn Hills Michigan 48326
Arcutis Clinical Site 41 Bay City Michigan 48706
Arcutis Clinical Site 36 Clarkston Michigan 48346
Arcutis Clinical Site 72 Troy Michigan 48084
Arcutis Clinical Site 05 New Brighton Minnesota 55112
Arcutis Clinical Site 47 Saint Joseph Missouri 64506
Arcutis Clinical Site 16 Reno Nevada 89509
Arcutis Clinical Site 55 Lebanon New Hampshire 03756
Arcutis Clinical Site 54 Brooklyn New York 11203
Arcutis Clinical Site 44 New York New York 11415
Arcutis Clinical Site 32 Rochester New York 14623
Arcutis Clinical Site 58 Cincinnati Ohio 45229
Arcutis Clinical Site 81 Mason Ohio 45040
Arcutis Clinical Site 01 Gresham Oregon 97030
Arcutis Clinical Site 52 Portland Oregon 97210
Arcutis Clinical Site 63 Portland Oregon 97239
Arcutis Clinical Site 65 Bethlehem Pennsylvania 18105
Arcutis Clinical Site 31 Hershey Pennsylvania 17033
Arcutis Clinical Site 24 Newtown Square Pennsylvania 19073
Arcutis Clinical Site 62 Charleston South Carolina 29425
Arcutis Clinical Site 39 Summerville South Carolina 29486
Arcutis Clinical Site 08 Austin Texas 78759
Arcutis Clinical Site 27 Bellaire Texas 77401
Arcutis Clinical Site 74 Fort Worth Texas 76244
Arcutis Clinical Site 66 Frisco Texas 75034
Arcutis Clinical Site 61 Grapevine Texas 76051
Arcutis Clinical Site 04 Houston Texas 77030
Arcutis Clinical Site 02 San Antonio Texas 78213
Arcutis Clinical Site 18 San Antonio Texas 78218
Arcutis Clinical Site 03 South Jordan Utah 84095
Arcutis Clinical Site 06 Burke Virginia 22015
Arcutis Clinical Site 76 Charlottesville Virginia 22902
Arcutis Clinical Site 25 Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

Recently updated Atopic Dermatitis Eczema trials

Other public records listing Atopic Dermatitis Eczema. Sorted by last update posted; newest first. Not a recommendation.

All Atopic Dermatitis Eczema trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04845620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04845620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →